RDGL.US Vivos Inc

Healthcare Health Care Equipment & Supplies USA Stocks
0.0405 USD
Close of Nov 17, 2026
0.0391 0.1244
Market cap
USD 20.8M
P/E
-
P/B
7.56x
ROE
-146.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is RDGL.US undervalued?

Graham number

The Graham number of Vivos Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Vivos Inc fundamental analysis

No fundamental analysis for Vivos Inc yet.

Vivos Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Vivos Inc

Vivos Inc., a radiation oncology medical device company, engages in the development of yttrium-90-based precision radionuclide therapy devices for the treatment of non-resectable tumors in the United States. The company develops RadioGel, which is an injectable particle-gel for Precision Radionuclide Therapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. It is also developing PLGA-g-PEG polymers; Precis…

Full company profile